Cargando…

Effect of levosimendan treatment on length of hospital and intensive care stay in the REVIVE I study

Detalles Bibliográficos
Autores principales:	Johansson, S, Apajasalo, M, Sarapohja, T, Garratt, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099675/ http://dx.doi.org/10.1186/cc2555

Ejemplares similares

Development of a comprehensive new endpoint for the evaluation of new treatments for acute decompensated heart failure: results with levosimendan in the REVIVE 1 study
por: Garratt, C, et al.
Publicado: (2004)

A systematic review of intensive care length of stay indicators
por: Burry, L
Publicado: (2004)

Study design of a mortality trial with intravenous levosimendan (the SURVIVE study) in patients with acutely decompensated heart failure
por: Mebazaa, A, et al.
Publicado: (2004)

Assessment of mortality post-ICU associated to the intensive care unit length of stay
por: Gómez Triana, F, et al.
Publicado: (2015)

Haemoglobin concentration on admission to intensive care influences hospital mortality rates and length of stay: a retrospective study
por: Adams, M, et al.
Publicado: (2013)

Effects of postoperative hyperlactatemia on patients' intensive therapy unit length of stay
por: Thanthulage, S, et al.
Publicado: (2008)

Length of hospital stay prior to ICU admission and outcome
por: Simpson, K, et al.
Publicado: (2011)

Theoretical framework for determining hospital length of stay (LOS)
por: Schorr, E
Publicado: (2012)

Efficacy of levosimendan in shock
por: McLean, A, et al.
Publicado: (2004)

Levosimendan in cardiac surgery
por: Harjola, V, et al.
Publicado: (2004)

Treatment of calcium channel blocker overdose with levosimendan
por: Sencan, A, et al.
Publicado: (2011)

Hemodynamic and volumetric response to levosimendan in critical care patients
por: Turani, F, et al.
Publicado: (2004)

Levosimendan use in critical care - a case series
por: Gibson, C, et al.
Publicado: (2015)

Hospital mortality and length of ICU stay in severely burned patients
por: Meier, S, et al.
Publicado: (2008)

Less fentanyl requirement by enteral methadone decreases mechanical ventilation duration and intensive care unit length of stay
por: Wanzuita, R, et al.
Publicado: (2007)

Intraoperative base excess and carbon dioxide gap predict length of intensive care stay after cardiac surgery
por: Hajjar, L, et al.
Publicado: (2008)

Exploring the relationship between the time until active rehabilitation and length of stay on an adult liver intensive care unit
por: Jerrard, K, et al.
Publicado: (2015)

Levosimendan: experience of an adult ICU
por: Lippett, S, et al.
Publicado: (2006)

Pre-ICU length of hospital stay is a predictor of hospital but not ICU mortality
por: Flavin, K, et al.
Publicado: (2015)

Dexmedetomidine versus standard care sedation with propofol or midazolam in intensive care: an economic evaluation
por: Turunen, Heidi, et al.
Publicado: (2015)

Levosimendan versus dobutamine in septic shock
por: Alhashemi, JA, et al.
Publicado: (2009)

Levosimendan versus dobutamine in cardiac surgery
por: Delgado-Amaya, MD, et al.
Publicado: (2015)

Intensive care unit length of stay beyond the first week and 1-year mortality - dutch single centre study in unselected critically ill patients describing long-term survival according to length of stay in conjunction with age
por: Soliman, IW, et al.
Publicado: (2015)

Lactate levels after major cardiac surgery are associated with hospital length of stay
por: Andersen, LW, et al.
Publicado: (2015)

Effect of prolonged emergency department length of stay on inpatient length of stay and inhospital mortality in severe sepsis and septic shock
por: Haji, K, et al.
Publicado: (2008)

Comparing intensive care treated primary, secondary and tertiary sepsis with respect to length of stay, organ failure and mortality: a pilot study
por: Castegren, S, et al.
Publicado: (2013)

Levosimendan in trauma patients with acute cardiac failure
por: Afonin, AN, et al.
Publicado: (2011)

Levosimendan versus dobutamine in Tako-tsubo cardiomyopathy
por: Righetti, FR, et al.
Publicado: (2013)

Levosimendan in myocardial depression due to severe sepsis
por: Malik, M, et al.
Publicado: (2007)

Use of levosimendan in myocardial dysfunction due to sepsis
por: Vaitsis, J, et al.
Publicado: (2009)

Haemodynamic effects of levosimendan following cardiac surgery
por: Slezina, A, et al.
Publicado: (2009)

Utilization of levosimendan in the cardiac ICU: case series
por: Filipescu, D, et al.
Publicado: (2009)

Blood transfusion after cardiac surgery increases the hospital length of stay in adult patients
por: Hajjar, L, et al.
Publicado: (2012)

Intensive care unit length of stay can be longer due to the low serum vitamin D levels in patients with chronic obstructive pulmonary disease
por: Keşkek, Ş Ö, et al.
Publicado: (2015)

The calcium sensitizer levosimendan reduces the brain natriuretic peptide levels as compared with dobutamine in intensive care unit septic patients with decompensated heart failure
por: Michalopoulou, H, et al.
Publicado: (2007)

Daily multidisciplinary rounds reduce ICU length of stay
por: Pacheco, ES, et al.
Publicado: (2011)

Analysis of ICU physician predictions for ICU length of stay
por: N Junior, Antonio Paulo, et al.
Publicado: (2015)

Increase in length of stay and overcost attributable to hospital-acquired infections in a pediatric unit in Senegal
por: Ndir, A, et al.
Publicado: (2011)

Influence of adverse drug events on the mortality and the length of hospital stay in ICUs in Japan: the JADE Study
por: Ohta, Y, et al.
Publicado: (2013)

The length of stay and the hospital cost for ICU patients with resistant bacterial infections: a pilot study
por: Priyendu, Asim, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_h1tm2jmploqvga5ud167r1mamu